BGM Group Ltd. SEC filings BGM
BGM Group Ltd. has 154 filings in SEC EDGAR's recent list, going back to Jun 17, 2019. Its latest annual report, Form 20-F, was filed on Jul 21, 2026 for the period ended Sep 30, 2025. The most recent current report (Form 6-K) was filed on Sep 24, 2026. The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 20-F | Filing | Jan 30, 2026 | Sep 30, 2025 |
| UPLOAD | Letter from the SEC | May 20, 2025 | — |
| CORRESP | Letter to the SEC | May 8, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2025 | — |
| CORRESP | Letter to the SEC | Apr 3, 2025 | — |
| EFFECT | Filing | Apr 2, 2025 | — |
| CORRESP | Letter to the SEC | Mar 31, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 24, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 17, 2025 | — |
| EFFECT | Filing | Nov 22, 2024 | — |
| CORRESP | Letter to the SEC | Nov 22, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2024 | — |
| EFFECT | Filing | May 16, 2024 | — |
| CORRESP | Letter to the SEC | May 15, 2024 | — |
| CORRESP | Letter to the SEC | May 8, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 18, 2024 | — |
| NT 20-F | Filing | Feb 1, 2024 | Sep 30, 2023 |
| NT 20-F | Filing | Jan 31, 2023 | Sep 30, 2022 |
| UPLOAD | Letter from the SEC | Oct 28, 2022 | — |
| CORRESP | Letter to the SEC | Oct 13, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 19, 2022 | — |
| CORRESP | Letter to the SEC | Jul 29, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2022 | — |
| CORRESP | Letter to the SEC | Jun 30, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2022 | — |
| NT 20-F | Form 12b-25 | Jan 31, 2022 | Sep 30, 2021 |
| CERT | Filing | Jan 11, 2021 | — |
| EFFECT | Filing | Dec 30, 2020 | — |
| CORRESP | Letter to the SEC | Dec 28, 2020 | — |
| CORRESP | Letter to the SEC | Dec 28, 2020 | — |
| 8-A12B | Filing | Dec 14, 2020 | — |
| CORRESP | Letter to the SEC | Dec 10, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 8, 2020 | — |
| CORRESP | Letter to the SEC | Jun 12, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2020 | — |
| CORRESP | Letter to the SEC | Jan 2, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 5, 2019 | — |
| CORRESP | Letter to the SEC | Nov 27, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 12, 2019 | — |
| CORRESP | Letter to the SEC | Nov 1, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2019 | — |
| DRS/A | Filing | Sep 9, 2019 | — |
| DRSLTR | Filing | Sep 6, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 11, 2019 | — |
| DRS | Filing | Jun 17, 2019 | — |
Showing 45 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BGM (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- Cayman Islands
- Headquarters
- Chengdu
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1779578
- Former names
- Qilian International Holding Group (until Oct 22, 2024); Qilian International Holding Group Ltd (until Oct 16, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.